Target
Uracil nucleotide/cysteinyl leukotriene receptor
Ligand
BDBM646691
Substrate
n/a
Meas. Tech.
GPR17 cAMP Assay Protocol
IC50
16.0±n/a nM
Citation
 GALLEY, GGOBBI, LGUBA, WMAZUNIN, DPINARD, ERICCI, A PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES US Patent  US20240025883 Publication Date 1/25/2024 
Target
Name:
Uracil nucleotide/cysteinyl leukotriene receptor
Synonyms:
GPR17 | GPR17_HUMAN
Type:
PROTEIN
Mol. Mass.:
41013.71
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1353471
Residue:
367
Sequence:
MSKRSWWAGSRKPPREMLKLSGSDSSQSMNGLEVAPPGLITNFSLATAEQCGQETPLENMLFASFYLLDFILALVGNTLALWLFIRDHKSGTPANVFLMHLAVADLSCVLVLPTRLVYHFSGNHWPFGEIACRLTGFLFYLNMYASIYFLTCISADRFLAIVHPVKSLKLRRPLYAHLACAFLWVVVAVAMAPLLVSPQTVQTNHTVVCLQLYREKASHHALVSLAVAFTFPFITTVTCYLLIIRSLRQGLRVEKRLKTKAVRMIAIVLAIFLVCFVPYHVNRSVYVLHYRSHGASCATQRILALANRITSCLTSLNGALDPIMYFFVAEKFRHALCNLLCGKRLKGPPPSFEGKTNESSLSAKSEL
  
Inhibitor
Name:
BDBM646691
Synonyms:
6-bromo-N-[5-(2,2- difluoroethyl)-4-methoxy- pyrimidin-2-yl]-7-methoxy-1H- indole-3-sulfonamide | US20240025883, Example 196
Type:
Small organic molecule
Emp. Form.:
C16H15BrF2N4O4S
Mol. Mass.:
477.281
SMILES:
COc1nc(NS(=O)(=O)c2c[nH]c3c(OC)c(Br)ccc23)ncc1CC(F)F
Structure:
Search PDB for entries with ligand similarity: